Evidence map›Paper›PMID 39885669›Full record

ReviewHuman vaccines & immunotherapeutics2025

Opportunities and challenges of immuno-oncology: A bibliometric analysis from 2014 to 2023.

Siqi Zhang, Lina Miao, Xiaoxia Tian, Bingxu Yang, Baoping Luo

Abstract readReview
In one paragraph

Review in Human vaccines & immunotherapeutics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Siqi ZhangSchool of Clinical Traditional Chinese Medicine, Hubei University of Chinese Medicine, Wuhan, China.
Lina MiaoXiyuan Hospital, China Academy of Chinese Medical Sciences, Beijing, China.
Xiaoxia TianSchool of Clinical Traditional Chinese Medicine, Hubei University of Chinese Medicine, Wuhan, China.
Bingxu YangSchool of Clinical Traditional Chinese Medicine, Hubei University of Chinese Medicine, Wuhan, China.
Baoping LuoSchool of Clinical Traditional Chinese Medicine, Hubei University of Chinese Medicine, Wuhan, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The emergence of immuno-oncology (IO) has led to revolutionary changes in the field of cancer treatment. Despite notable advancements in this field, a thorough exploration of its full depth and extent has yet to be performed. This study provides a comprehensive overview of publications pertaining to IO. Publications on IO from 2014 to 2023 were retrieved by searching the Web of Science Core Collection database (WoSCC). VOSviewer software and Citespace software were used for the visualized analysis. A total of 1,874 articles have been published in the IO domain. The number of publications and citations has been increasing annually. This study also examines the primary research directions within the field of IO. In conclusion, this study offers a comprehensive overview of the opportunities and challenges associated with IO, illuminating the current status of research and indicating potential future trajectories in this rapidly progressing field. This study provides a comprehensive survey of the current research status and hot spots within the field of IO. It will assist researchers in comprehending the current research emphasis and development trends in this field and offers guidance for future research directions.

Indexed as

BibliometricsImmunotherapyMedical OncologyNeoplasmsBiomedical ResearchHumansbibliometricsCiteSpaceImmuno-oncologyimmunotherapyvisual analysis

Identifiers

PMID39885669
PMCPMC11792843

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.